AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $565,000 | +102.5% | 37,375 | +0.5% | 0.00% | +100.0% |
| Q2 2022 | $279,000 | -17.9% | 37,192 | -0.6% | 0.00% | 0.0% |
| Q1 2022 | $340,000 | +25.5% | 37,412 | +57.2% | 0.00% | 0.0% |
| Q3 2021 | $271,000 | -29.6% | 23,803 | -1.1% | 0.00% | -50.0% |
| Q2 2021 | $385,000 | -11.7% | 24,062 | -1.6% | 0.00% | 0.0% |
| Q1 2021 | $436,000 | +25.3% | 24,447 | -5.0% | 0.00% | 0.0% |
| Q4 2020 | $348,000 | – | 25,739 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |